LEADER 02751nam  22009013u 450 
001 9910972032203321
005 20240416172505.0
010   $a9782742012343
010   $a2742012346
035   $a(CKB)3710000000025020
035   $a(EBL)3317898
035   $a(SSID)ssj0001048635
035   $a(PQKBManifestationID)12381905
035   $a(PQKBTitleCode)TC0001048635
035   $a(PQKBWorkID)11017933
035   $a(PQKB)11028185
035   $a(PPN)185797083
035   $a(FR-PaCSA)88821148
035   $a(MiAaPQ)EBC3317898
035   $a(FRCYB88821148)88821148
035   $a(EXLCZ)993710000000025020
100   $a20151005d2014||||  u||         |
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aOrphan Drugs in Epilepsy
205   $a1st ed.
210   $aMontrouge $cJOHN LIBBEY EUROTEXT$d2014
215   $a1 online resource (90 p.)
225 1 $aTopics in Epilepsy ;$vv.4
300   $aDescription based upon print version of record.
311 08$a9782742008100 
311 08$a2742008101 
327   $a""Orphan Drugs in Epilepsy""; ""Contents""; ""Foreword""; ""Bromides""; ""Adrenocorticotropic hormone and corticosteroids""; ""Stiripentol""; ""Felbamate""; ""Rufinamide""
410  0$aTopics in Epilepsy
606   $aEpilepsy -- Treatment
606   $aBrain Diseases
606   $aCentral Nervous System Agents
606   $aDrug Industry
606   $aIndustry
606   $aTherapeutic Uses
606   $aCentral Nervous System Diseases
606   $aNervous System Diseases
606   $aTechnology, Industry, and Agriculture
606   $aPharmacologic Actions
606   $aChemical Actions and Uses
606   $aDisease
606   $aAnticonvulsants
606   $aEpilepsy
606   $aOrphan Drug Production
615  4$aEpilepsy -- Treatment.
615  2$aBrain Diseases.
615  2$aCentral Nervous System Agents.
615  2$aDrug Industry.
615  2$aIndustry.
615  2$aTherapeutic Uses.
615  2$aCentral Nervous System Diseases.
615  2$aNervous System Diseases.
615  2$aTechnology, Industry, and Agriculture.
615  2$aPharmacologic Actions.
615  2$aChemical Actions and Uses.
615  2$aDisease.
615  2$aAnticonvulsants.
615  2$aEpilepsy.
615  2$aOrphan Drug Production.
676   $a616.853
700   $aNikanorova$b Marina$01796203
701   $aJohannessen$b Svein I$01796204
701   $aGenton$b Pierre$01679223
801  0$bAU-PeEL
801  1$bAU-PeEL
801  2$bAU-PeEL
906   $aBOOK
912   $a9910972032203321
996   $aOrphan Drugs in Epilepsy$94337874
997   $aUNINA

LEADER 01343nam  22004333  450 
001 9911028649303321
005 20250930085251.0
010   $a981-9507-92-8
035   $a(MiAaPQ)EBC32320629
035   $a(Au-PeEL)EBL32320629
035   $a(CKB)41018805600041
035   $a(OCoLC)1545638172
035   $a(EXLCZ)9941018805600041
100   $a20250930d2025      uy         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFollowing the Crowd
205   $a1st ed.
210  1$aSingapore :$cSpringer,$d2025.
210  4$dİ2025.
215   $a1 online resource (330 pages)
225 1 $aEconomics and Finance Series
311 08$a981-9507-91-X 
330   $aThis book delves into a comprehensive exploration of herding and market overreaction combining psychological insights to understand why investors follow the crowd and the investment tips of others.
410  0$aEconomics and Finance Series
676   $a332.6019
700   $aOoi$b Kok Loang$01784664
701   $aBinti Ab Aziz$b Norazlin$01849069
701   $aLau$b Wee Yeap$01738102
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9911028649303321
996   $aFollowing the Crowd$94438073
997   $aUNINA